ArTS Archivio della ricerca di Trieste

RUARO, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.339
NA - Nord America 6.791
EU - Europa 4.814
SA - Sud America 1.367
AF - Africa 227
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.495
SG - Singapore 2.475
IT - Italia 1.802
CN - Cina 1.426
BR - Brasile 1.100
VN - Vietnam 1.020
HK - Hong Kong 738
BD - Bangladesh 463
KR - Corea 428
DE - Germania 373
FR - Francia 335
GB - Regno Unito 332
SE - Svezia 286
NL - Olanda 267
FI - Finlandia 258
PL - Polonia 236
RU - Federazione Russa 206
BG - Bulgaria 163
IN - India 161
IE - Irlanda 153
CA - Canada 133
AR - Argentina 98
MX - Messico 90
AT - Austria 82
ID - Indonesia 75
CH - Svizzera 73
IQ - Iraq 72
MA - Marocco 67
TR - Turchia 63
JP - Giappone 62
ES - Italia 54
ZA - Sudafrica 49
EC - Ecuador 43
IR - Iran 39
PK - Pakistan 38
SA - Arabia Saudita 38
PH - Filippine 35
AU - Australia 34
CO - Colombia 34
UA - Ucraina 34
EG - Egitto 28
UZ - Uzbekistan 26
CL - Cile 25
TH - Thailandia 22
PY - Paraguay 21
CZ - Repubblica Ceca 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 19
RO - Romania 19
BE - Belgio 17
GR - Grecia 15
JO - Giordania 13
KE - Kenya 13
MY - Malesia 13
TW - Taiwan 13
IL - Israele 12
SN - Senegal 12
AZ - Azerbaigian 11
JM - Giamaica 11
PE - Perù 11
RS - Serbia 11
DZ - Algeria 10
HN - Honduras 10
KZ - Kazakistan 10
OM - Oman 10
PA - Panama 10
TN - Tunisia 10
CR - Costa Rica 9
NP - Nepal 9
PT - Portogallo 9
AO - Angola 8
DK - Danimarca 8
LK - Sri Lanka 8
AL - Albania 7
BO - Bolivia 7
HU - Ungheria 7
UY - Uruguay 7
BY - Bielorussia 6
HR - Croazia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
KG - Kirghizistan 5
LT - Lituania 5
CI - Costa d'Avorio 4
LB - Libano 4
LU - Lussemburgo 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
YE - Yemen 4
CG - Congo 3
CU - Cuba 3
EU - Europa 3
GE - Georgia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 20.522
Salva come PNG Salva come JPEG
Città #
Singapore 1.409
Ashburn 873
San Jose 755
Hong Kong 715
Chandler 464
Seoul 419
Hefei 414
Council Bluffs 384
Ho Chi Minh City 337
Beijing 315
Trieste 301
Hanoi 251
Boardman 214
Los Angeles 211
Santa Clara 189
Dallas 188
Chicago 187
Lauterbourg 160
Princeton 158
Sofia 158
Columbus 156
Milan 151
New York 146
Dublin 143
Zgierz 142
Helsinki 139
London 137
São Paulo 113
Redmond 111
The Dalles 104
Moscow 97
Frankfurt am Main 94
Lappeenranta 78
Munich 78
Wilmington 75
Warsaw 74
Rome 70
Buffalo 66
Vienna 61
Haiphong 49
Bern 48
Amsterdam 47
Montreal 47
Naples 46
Turin 46
Casablanca 44
Tokyo 43
Nuremberg 40
Da Nang 39
Rio de Janeiro 37
Orem 36
Boydton 35
Denver 35
Turku 35
Manchester 34
Atlanta 33
Mexico City 32
Toronto 31
Florence 30
Phoenix 30
Cividale del Friuli 29
Udine 29
Bremen 28
Shanghai 28
Düsseldorf 27
Baghdad 26
Redondo Beach 26
Tehran 26
Chennai 25
Seattle 25
Guangzhou 24
Dong Ket 23
Johannesburg 23
Miano 23
Paris 23
Houston 21
Mumbai 21
Tashkent 21
Brooklyn 19
Hangzhou 19
North Bergen 19
Bologna 18
Brasília 18
Curitiba 18
Guayaquil 18
Stockholm 18
Woodbridge 18
Barnet 17
Campinas 17
Jacksonville 17
Porto Alegre 17
Treviso 17
Bangkok 16
Bari 16
Dhaka 16
Quito 16
Shenzhen 16
Venice 16
Washington 16
Ankara 15
Totale 11.779
Salva come PNG Salva come JPEG
Nome #
Alveolar Epithelial Type II Cells 396
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 391
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 258
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 236
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 235
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 226
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 215
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 213
Chronic Thromboembolic Pulmonary Hypertension: An Update 213
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 210
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 204
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 203
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 197
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 196
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 195
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 195
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 192
The Treatment of Lung Involvement in Systemic Sclerosis 189
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 189
Aging-Related Findings of the Respiratory System in Chest Imaging: Pearls and Pitfalls 188
Accuracy of CT-Guided Core-Needle Biopsy in Diagnosis of Thoracic Lesions Suspicious for Primitive Malignancy of the Lung: A Five-Year Retrospective Analysis 186
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 184
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 183
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 181
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 178
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 169
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 167
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 166
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 165
Advanced in naifold capillaroscopic analysis in systemic sclerosis 165
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 164
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 161
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 159
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 157
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 157
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 155
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement 155
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 154
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 153
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 153
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 152
Editorial: Evolution in respiratory pharmacology 151
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 150
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 147
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 145
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 144
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 144
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 143
Host-Based Treatments for Severe COVID-19 141
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 141
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 141
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 141
A Systematic Review of In-situ Aortic Reconstructions for Abdominal Aortic Graft and Endograft Infections: Outcomes of Currently Available Options for Surgical Replacement 140
Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome 140
Comorbidities’ Effect on IPF: Pathogenesis and Management 139
Calcified Lung Nodules: A Diagnostic Challenge in Clinical Daily Practice 138
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 138
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 137
Advances in Diagnostics and Management of Respiratory System Diseases 135
Pulmonary fibrosis: one manifestation, various diseases 134
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 134
Digital Ulcers in Systemic Sclerosis 133
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 131
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 130
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 130
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 130
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 130
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 129
Novel Technique for Intentional Occlusion of Directional Branches During Complex Endovascular Aortic Repair Using Microvascular Plugs 129
Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization - WSF Skin Ultrasound Group 128
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 127
Monitoring COVID-19 pneumonia undergoing non-invasive respiratory support (NIRS), correlation between oscillometric reactance and Thoracic CT 125
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS). WHAT’S NEW? 125
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 125
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 124
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 124
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients 123
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 122
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 122
Clinical Applications of Contrast-Enhanced Ultrasonography (CEUS) in Vascular Surgery: State-of-the-Art Narrative and Pictorial Review 122
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 121
Biomarkers in Systemic Sclerosis: An Overview 119
Correlation between bone quality and microvascular damage in systemic sclerosis patients 118
A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review 115
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis   115
Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS 115
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 114
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 114
Capillaroscopy 2016: new perspectives in systemic sclerosis 113
A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019 110
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 110
Pulmonary Fibrosis: one manifestation, various diseases 107
Don't forget the jumper's knee in the young sportsman: evaluation of patellar tendinopathy with a high frequency ultrasound probe 107
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis 107
Editorial: Osteoporosis in Rheumatic Diseases, What's New? 105
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 104
Digital Tomosynthesis as a Problem-Solving Technique to Confirm or Exclude Pulmonary Lesions in Hidden Areas of the Chest 103
Ultrasonography for the assessment of skin in systemic sclerosis: a systematic review 103
Peripheral blood perfusion in patients with systemic lupus erythematosus and in primary Raynaud's phenomenon 101
Totale 15.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/20221.036 41 38 35 70 16 96 82 47 231 47 62 271
2022/20231.614 169 211 131 152 144 263 44 127 191 39 94 49
2023/20241.735 105 86 115 98 165 155 331 323 40 50 138 129
2024/20254.365 82 405 464 293 309 276 306 255 493 526 431 525
2025/202612.167 843 672 1.030 1.542 825 867 1.456 542 1.242 1.537 993 618
Totale 21.155